Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
RituxiRel (Rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. At present, Rituximab is the most important mAb of clinical value in patients with B-cell lymphoid malignancies. Rituximab has an approximate molecular weight of 145 kDa.
VRAJ LIFE SCIENCE
Other Products in 'Pharmaceutical Injection' category